These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36999941)

  • 21. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The benefit/risk of good therapeutics.
    Novack GD
    Ocul Surf; 2012 Oct; 10(4):264-6. PubMed ID: 23084147
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical Manipulations for Ocular Drug Delivery.
    Tiwary AK
    Recent Pat Drug Deliv Formul; 2019; 13(4):244-245. PubMed ID: 32400325
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space.
    Patel SR; Prausnitz MR
    J Ocul Pharmacol Ther; 2016 Dec; 32(10):640-641. PubMed ID: 27849435
    [No Abstract]   [Full Text] [Related]  

  • 26. A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs.
    Ribeiro IS; Batel Marques FJ; Alves DG; Alves CMC
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):421-430. PubMed ID: 30722711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye.
    Cheng KJ; Hsieh CM; Nepali K; Liou JP
    J Med Chem; 2020 Oct; 63(19):10533-10593. PubMed ID: 32482069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Product Creativity as an Identity Issue: Through the Eyes of New Product Development Team Members.
    Park JS; Suzuki S
    Front Psychol; 2021; 12():646766. PubMed ID: 34335363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):401-2. PubMed ID: 27513031
    [No Abstract]   [Full Text] [Related]  

  • 32. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):705-706. PubMed ID: 29064309
    [No Abstract]   [Full Text] [Related]  

  • 33. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):645-646. PubMed ID: 28945153
    [No Abstract]   [Full Text] [Related]  

  • 34. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):573. PubMed ID: 28813632
    [No Abstract]   [Full Text] [Related]  

  • 35. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):485-486. PubMed ID: 32706606
    [No Abstract]   [Full Text] [Related]  

  • 36. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Oct; 36(8):579. PubMed ID: 32865477
    [No Abstract]   [Full Text] [Related]  

  • 37. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2022 Dec; 38(10):655-656. PubMed ID: 36378872
    [No Abstract]   [Full Text] [Related]  

  • 38. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020; 36(6):321-322. PubMed ID: 32564666
    [No Abstract]   [Full Text] [Related]  

  • 39. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2021; 37(1):1-3. PubMed ID: 33449858
    [No Abstract]   [Full Text] [Related]  

  • 40. Eyes on New Product Development.
    Novack GD
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):711-712. PubMed ID: 33085909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.